Lowest Price Guaranteed From USD 4,499
Published
May 2019
Pages
323
View Count
21328
Example Insights
 |
 |
 |
 |
.png) |
 |
 |
 |
Report Description
-This image presents current market landscape of
The global medical device CMO market is currently worth around $54.1 billion and is expected to grow at a CAGR 8.0% during the forecast period. Recent advances in data science technology solutions, such as Internet of Things, machine learning, artificial intelligence and real world evidence-based solutions, have enabled medical device developers to digitize and automate a number of product development and manufacturing processes. In 2020, the global medical devices market is estimated to reach a net worth of approximately USD 430 billion. However, most developers lack adequate resources and the necessary expertise to manufacture medical devices and related components. Moreover, given the rapid rate of evolution, the costs associated with acquiring the necessary infrastructure and capabilities in this field are high; therefore, it is difficult for companies with limited finances to acquire such resources and carry out such operations by themselves. In addition, the evolving regulatory guidelines and complicated pathways to establishing reimbursement strategies render medical devices subject to rigorous quality assessments, especially for medium and high risk devices. The aforementioned constraints have led many of the smaller players and certain established players to outsource a significant part of their manufacturing operations to capable contract manufacturing organizations (CMOs). CMOs are known to offer significant cost-benefits, access to sophisticated / up-to-date infrastructure, large production capacities and reduction in time-to-market.
Given the demand for medical devices, the opportunity for CMOs with expertise in medical devices is steadily rising. In fact, in 2018 alone, the USFDA approved over 100 medical devices. It is worth highlighting that, since 2000, more than 65 CMOs have been established. The demand for one-stop-shops and versatile supply chain management solutions have fuelled consolidation activity in this domain. Contemporary contract service providers have been focusing on bolstering in-house capabilities to offer a wider range of services to their clients, covering product design to distribution and marketing, along with regulatory assistance. The medical device sector is among the most highly regulated industries, and we expect the demand for core competencies, such as design and engineering, prototype development and high volume manufacturing, to continue to drive sponsor companies to outsource various parts of their product development and manufacturing operations to capable contract service providers. Amidst tough competition, the availability of advanced tools and technologies is an important differentiating factor; CMOs that invest in such upgrades are likely to gain a competitive edge.
The “Medical Device CMOs Market, 2019-2030” report features a comprehensive study on the current landscape of contract manufacturing service providers focused on medical devices (specifically for drug-delivery devices, diagnostic devices and therapeutic devices). The scope of the report primarily includes those manufacturers that offer finished product services for medical devices (excluding medical equipment, such as X-ray machines, ultrasound machines, operating tables and other similar products). The study features an in-depth analysis, highlighting the capabilities of the various stakeholders engaged in this domain, across different regions of the globe. Amongst other elements, the report includes:
One of the key objectives of this report was to evaluate the current opportunity and the future market potential of the medical device CMOs market over the coming decade. We have provided an informed estimate of the likely evolution of the market in the short to mid-term and long term, for the period 2019-2030. In addition, we have provided the likely distribution of the opportunity across different [A] type of devices (drug-delivery, therapeutic and diagnostic devices), [B] device class (class I, class II and class III), [C] therapeutic areas (cardiovascular disorders, CNS disorders, metabolic disorders, oncological disorders, orthopedic disorders, ophthalmic disorders, pain disorders, respiratory disorders, and others), and [D] geographical regions (North America, Europe, Asia-Pacific and rest of the world) and [E] leading players. To account for the uncertainties associated with the growth of the medical device CMO market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Contents
Chapter 2 is an executive summary of the key insights captured in our research. It offers a high-level view on the current state of the medical device contract manufacturing market and its likely evolution in the short-mid and long terms.
Chapter 3 provides a brief introduction to medical devices, highlighting key historical milestones, their classification, and associated manufacturing requirements. It emphasizes on the contract services market for such medical products, featuring an overview of the various challenges faced by medical device manufacturers, and highlighting the role of CMOs and diverse range of benefits offered by such service provider entities. It also includes a discussion on the services offered by CMOs, along with a list of advantages and risks associated with outsourcing. Further, it describes the various factors that need to be taken into consideration by sponsor companies, while selecting a suitable CMO partner.
Chapter 4 features a detailed discussion on the various guidelines established by regulatory bodies for medical device approval, across different geographical regions, namely North America (the US and Canada), Europe (specifically the UK scenario), and Asia-Pacific (Japan, China and Australia). In addition, the chapter features an insightful, multi-dimensional bubble analysis that compares the current regulatory scenario within the overall medical device industry.
Chapter 5 provides a comprehensive overview of the overall landscape of drug-delivery device CMOs. It includes information related to over 70 companies that actively offer manufacturing services for drug-delivery devices. In addition, it features an in-depth analysis of the market, based on parameters such as year of establishment, size of employee base, location of manufacturing facility, scale of operation (precommercial and commercial) and types of services offered.
Chapter 6 provides a comprehensive overview of the overall landscape of diagnostic device CMOs. It includes information related to over 80 companies that actively offer manufacturing services for diagnostic devices. In addition, it features an in-depth analysis of the market, based on parameters such as year of establishment, size of employee base, location of manufacturing facility, scale of operation (precommercial and commercial) and types of services offered.
Chapter 7 provides a comprehensive overview of the global landscape of therapeutic device CMOs. It includes information related to over 170 companies that actively offer manufacturing services for therapeutic devices. In addition, it features an in-depth analysis of the market, based on parameters such as year of establishment, size of employee base, location of manufacturing facility, scale of operation (precommercial and commercial) and types of services offered.
Chapter 8 presents a benchmark analysis of the various players engaged in this domain. It highlights the capabilities of small-sized, mid-sized and large companies in terms of their expertise in medical device related services. Further, the analysis allows companies to compare their existing capabilities within and beyond their respective peer groups, providing a means for stakeholders to identify ways to gain a competitive edge in the industry.
Chapter 9 features an analysis of the medical device value-chain, highlighting the role of CMOs engaged in this domain and analysis based on services such as, such as supply chain management services, logistics services, warehouse services and shipping services.
Chapter 10 features detailed profiles of popular players that specialize in providing services for both precommercial and commercial stage medical device manufacturing. Each profile features an overview of the company, its service portfolio, details on manufacturing facilities, and an informed future outlook.
Chapter 11 presents a geographical clinical trial analysis of ongoing and planned studies related to medical devices. For the purpose of this analysis, we considered those clinical studies that have been initiated since 2013 and analysed them on the basis of various parameters, such as year of registration, regional distribution, current status of trials, phase of development, funder type, therapeutic area(s) and target disease indication(s), and number of patients enrolled across different geographies.
Chapter 12 features a detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2014-2019, based on parameters such as key value drivers, year of acquisition, type of acquisition, geographical location of the acquirer and the acquired company, and financial details of the deal (if available). The analysis also features an ownership change matrix, providing insights on the involvement of private and public sector entities in this domain. In addition, the chapter evaluates the deal multiples of acquisitions specifically focused on medical devices, analyzing them based on a number of parameters, namely annual revenues, number of employees and the experience of the acquired company. Moreover, it presents a schematic world map representation of the geographical distribution of this activity, highlighting inter- and intracontinental deals.
Chapter 13 features a case study highlighting the manufacturing overview of key market sectors, such as automobiles, telecommunication, banking, defense and aerospace that have experienced tremendous growth within emerging markets. It highlights the ongoing evolution in medical device manufacturing industry within developed and emerging countries, featuring a qualitative comparative analysis. Further, the chapter includes discussions regarding the business models, associated challenges and strategies to mitigate these constraints for multinational, medical device-focused companies within emerging countries.
Chapter 14 presents a likely evolution of the market in the short to mid-term and long term (2018-2030). In addition, we have provided the likely distribution of the opportunity across different A] type of device (drug-delivery, therapeutic and diagnostic devices), [B] device class (class I, class II and class III), therapeutic areas (cardiovascular disorders, CNS disorders, metabolic disorders, oncological disorders, orthopedic disorders, ophthalmic disorders, pain disorders, respiratory disorders, and others), and [D] geographical regions (North America, Europe, Asia-Pacific and rest of the world) and [E] leading players.
Chapter 15 provides a discussion on affiliated trends, key drivers and challenges, under a comprehensive SWOT framework, featuring a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall medical devices CMO industry.
Chapter 16 is a summary of the entire report. It provides the key takeaways and presents our independent opinion of the medical device CMOs market, based on the research and analysis described in the previous chapters. It also provides a recap of some of the upcoming future trends, which, we believe, are likely to influence the growth of medical device CMOs.
Chapter 17 is a collection of survey transcripts of the discussions held with key stakeholders in this market.
Chapter 18 is an appendix that contains tabulated data and numbers for all the figures provided in the report.
Chapter 19 is an appendix that contains the list of companies and organizations mentioned in this report.
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Medical Devices: An Overview
3.2.1. History of Medical Devices
3.2.2. Classification of Medical Devices
3.3. Medical Device Manufacturing
3.3.1. Challenges Associated with Medical Device Manufacturing
3.3.2. Role of CMOs in Medical Device Manufacturing
3.3.3. Role of Automation in Medical Device Manufacturing Process
3.4. Historical Timeline for Medical Device CMOs
3.5. Services Offered by Medical Device CMOs
3.6. Advantages Offered by Medical Device CMOs
3.7. Risks associated with Outsourcing to CMOs
3.8. Key Considerations
3.9. Concluding Remarks
4. REGULATORY LANDSCAPE FOR MEDICAL DEVICES
4.1. Chapter Overview
4.2. General Regulatory Guidelines for Medical Devices
4.3. Regulatory Landscape in North America
4.3.1. The US Scenario
4.3.1.1. Regulatory Authority
4.3.1.2. Review / Approval Process
4.3.2. The Canadian Scenario
4.3.2.1. Regulatory Authority
4.3.2.2. Review / Approval Process
4.4. Regulatory Landscape in Europe
4.4.1. Overall Scenario
4.4.1.1. Regulatory Authority
4.4.1.2. Review / Approval Process
4.4.2. Case Study: Brexit -The UK Scenario
4.5. Regulatory Landscape in Asia-Pacific
4.5.1. The Chinese Scenario
4.5.1.1. Regulatory Authority
4.5.1.2. Review / Approval Process
4.5.2. The Japanese Scenario
4.5.2.1. Regulatory Authority
4.5.2.2. Review / Approval Process
4.5.3. The Australian Scenario
4.5.3.1. Regulatory Authority
4.5.3.2. Review / Approval Process
4.6. Comparison of Regional Regulatory Environment
5. MARKET OVERVIEW: THERAPEUTIC DEVICES
5.1. Chapter Overview
5.2. Medical Device CMOs Offering Services for Therapeutic Devices
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Size of Employee Base
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Location of Manufacturing Facility
5.2.5. Analysis by Regulatory Certifications / Accreditations
5.2.6. Analysis by Production Services Offered
5.2.7. Analysis by Post-production Services Offered
5.2.8. Analysis by Other Services Offered
5.2.9. Analysis by Device Class
5.2.10. Analysis by Type of Material(s) Handled
5.2.11. Analysis by Scale of Operation
5.2.12. Leading Players
6. MARKET OVERVIEW: DIAGNOSTIC DEVICES
6.1. Chapter Overview
6.2. Medical Device CMOs Offering Services for Diagnostic Devices
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Size of Employee Base
6.2.3. Analysis by Location of Headquarters
6.2.4. Analysis by Location of Manufacturing Facility
6.2.5. Analysis by Regulatory Certifications / Accreditations
6.2.6. Analysis by Production Services Offered
6.2.7. Analysis by Post-Production Services Offered
6.2.8. Analysis by Other Services Offered
6.2.9. Analysis by Device Class
6.2.10. Analysis by Type of Material(s) Handled
6.2.11. Analysis by Scale of Operation
6.2.12. Leading Players
7. MARKET OVERVIEW: DELIVERY SYSTEMS AND OTHERS
7.1. Chapter Overview
7.2. Catheters
7.2.1. Medical Device CMOs Offering Services for Catheters
7.2.2. Analysis by Year of Establishment
7.2.3. Analysis by Size of Employee Base
7.2.4. Analysis by Location of Headquarters
7.2.5. Analysis by Location of Manufacturing Facility
7.2.6. Analysis by Regulatory Certifications / Accreditations
7.2.7. Analysis by Production Services Offered
7.2.8. Analysis by Post-Production Services Offered
7.2.9. Analysis by Other Services Offered
7.2.10. Analysis by Device Class
7.2.11. Analysis by Type of Material(s) Handled
7.2.12. Analysis by Scale of Operation
7.2.13. Leading Players
7.3. Drug Delivery Devices
7.3.1. Medical Device CMOs Offering Services for Drug Delivery Devices
7.3.2. Analysis by Year of Establishment
7.3.3. Analysis by Size of Employee Base
7.3.4. Analysis by Location of Headquarters
7.3.5. Analysis by Location of Manufacturing Facility
7.3.6. Analysis by Regulatory Certifications / Accreditations
7.3.7. Analysis by Production Services Offered
7.3.8. Analysis by Post-Production Services Offered
7.3.9. Analysis by Other Services Offered
7.3.10. Analysis by Device Class
7.3.11. Analysis by Type of Material(s) Handled
7.3.12. Analysis by Scale of Operation
7.3.13. Leading Players
7.4. Other Devices
7.4.1. Medical Device CMOs Offering Services for Other Medical Devices
7.4.2. Analysis by Year of Establishment
7.4.3. Analysis by Size of Employee Base
7.4.4. Analysis by Location of Headquarters
7.4.5. Analysis by Location of Manufacturing Facility
7.4.6. Analysis by Regulatory Certifications / Accreditations
7.4.7. Analysis by Production Services Offered
7.4.8. Analysis by Post-Production Services Offered
7.4.9. Analysis by Other Services Offered
7.4.10. Analysis by Device Class
7.4.11. Analysis by Type of Material(s) Handled
7.4.12. Analysis by Scale of Operation
8. BENCHMARK ANALYSIS
8.1. Chapter Overview
8.2. Benchmark Analysis: Methodology
8.3. Region-wise Benchmark Analysis
8.3.1. North America, Peer Group I
8.3.2. North America, Peer Group II
8.3.3. North America, Peer Group III
8.3.4. North America, Peer Group IV
8.3.5. North America, Peer Group V
8.3.6. North America, Peer Group VI
8.3.7. North America, Peer Group VII
8.3.8. Europe, Peer Group VIII
8.3.9. Europe, Peer Group IX
8.3.10. Europe, Peer Group X
8.3.11. Asia, Peer Group XI
8.3.12. Asia, Peer Group XII
8.4. Concluding Remarks
9. SUPPLY CHAIN ANALYSIS
9.1. Chapter Overview
9.2. Overview of the Medical Device Supply Chain
9.3. Factors Affecting the Medical Device Supply Chain
9.4. Key Performance Indicators
9.5. Supply Chain Improvement Strategies
9.5.1. Optimization of Supply Chain Capabilities
9.5.2. Visible Supply Chain and Related Advantages
9.5.2.1. Augmenting Supply Chain Visibility Through Digitalization
9.5.2.2. Benefits of Digital Supply Chain
9.6. Effects of Supply Chain Optimization
9.7. Cost Analysis
9.7.1. Production-related Costs
9.7.1.1. Labor Costs
9.7.1.2. Raw Materials Related Costs
9.7.1.3. Regulatory Compliance
9.7.1.4. Technology-related Costs
9.7.2. Supply Chain-related Costs
9.7.2.1. Local Presence
9.7.2.2. Geopolitical Risk
9.7.2.3. Logistics
10. COMPANY PROFILES
10.1. Chapter Overview
10.2. CMOs Headquartered in North America
10.2.1. Cirtec Medical
10.2.1.1. Company Overview
10.2.1.2. Service Portfolio
10.2.1.3. Manufacturing Capabilities and Facilities
10.2.1.3.1. Facilities located in North America
10.2.1.3.2. Facilities Located in Europe
10.2.1.4. Future Outlook
10.2.2. DynaFlex Technologies
10.2.2.1. Company Overview
10.2.2.2. Service Portfolio
10.2.2.3. Manufacturing Capabilities and Facilities
10.2.2.4. Future Outlook
10.2.3. I-Tek Medical Technologies
10.2.3.1. Company Overview
10.2.3.2. Service Portfolio
10.2.3.3. Manufacturing Capabilities and Facilities
10.2.3.4. Future Outlook
10.2.4. Keystone Solutions Group
10.2.4.1. Company Overview
10.2.4.2. Service portfolio
10.2.4.3. Manufacturing Facilities
10.2.4.4. Future Outlook
10.2.5. Oscor
10.2.5.1. Company Overview
10.2.5.2. Service Portfolio
10.2.5.3. Manufacturing Capabilities and facilities
10.2.5.4. Future Outlook
10.2.6. SMC
10.2.6.1. Company Overview
10.2.6.2. Service Portfolio
10.2.6.3. Manufacturing Capabilities and facilities
10.2.6.3.1. Facilities Located in North America
10.2.6.3.2. Facility Located in Central America
10.2.6.3.3. Facility Located in Europe
10.2.6.3.4. Facility Located in Asia
10.2.6.4. Future Outlook
10.2.7. Stellartech Research
10.2.7.1. Company Overview
10.2.7.2. Service Portfolio
10.2.7.3. Manufacturing Capabilities and facilities
10.2.7.4. Future Outlook
10.3. CMOs Headquartered in Europe
10.3.1. Creganna Medical
10.3.1.1. Company Overview
10.3.1.2. Service Portfolio
10.3.1.3. Manufacturing Facilities
10.3.1.3.1. Facilities Located in North America
10.3.1.3.2. Facilities Located in Central America
10.3.1.3.3. Facilities Located in Europe
10.3.1.3.4. Facilities Located in Asia
10.3.1.4. Future Outlook
10.3.2. Europlaz Technologies
10.3.2.1. Company Overview
10.3.2.2. Service Portfolio
10.3.2.3. Manufacturing facilities
10.3.2.4. Future Outlook
10.3.3. Riverside Medical Packaging
10.3.3.1. Company Overview
10.3.3.2. Service Portfolio
10.3.3.3. Manufacturing Facilities
10.3.3.4. Future Outlook
10.3.4. Synecco
10.3.4.1. Company Overview
10.3.4.2. Service Portfolio
10.3.4.3. Manufacturing Facilities
10.3.4.3.1. Facilities Located in Europe
10.3.4.3.2. Facilities Located in Asia
10.3.4.4. Future Outlook
10.3.5. Trelleborg Sealing Solutions
10.3.5.1. Company Overview
10.3.5.2. Service Portfolio
10.3.5.3. Manufacturing Facilities
10.3.5.3.1. Facilities Located in North America
10.3.5.3.2. Facilities Located in Europe
10.3.5.4. Future Outlook
10.4. CMOs Headquartered in Asia
10.4.1. Interplex
10.4.1.1. Company Overview
10.4.1.2. Service Portfolio
10.4.1.3. Manufacturing Facilities
10.4.1.3.1. Facilities Located in North America
10.4.1.3.2. Facilities Located in Europe
10.4.1.3.3. Facilities Located in Asia
10.4.1.4. Future Outlook
10.4.2. Modern Medical
10.4.2.1. Company Overview
10.4.2.2. Service Portfolio
10.4.2.3. Manufacturing facilities
10.4.2.4. Future Outlook
10.4.3. Providence Enterprise
10.4.3.1. Company Overview
10.4.3.2. Service Portfolio
10.4.3.3. Manufacturing Facilities
10.4.3.4. Future Outlook
10.4.4. Suzhou Jenitek
10.4.4.1. Company overview
10.4.4.2. Service Portfolio
10.4.4.3. Manufacturing Facilities
10.4.4.4. Future Outlook
11. CLINICAL TRIAL ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Clinical Trial Analysis: Word Cloud of Trial Titles
11.4. Analysis of Clinical Trials
11.4.1. Analysis by Trial Start Year
11.4.2. Analysis by Trial Status
11.4.3. Analysis by Phase of Development
11.4.4. Analysis by Target Indication
11.4.5. Analysis by Type of Sponsor
11.4.6. Analysis by Geography
11.4.7. Analysis by Trial Start Year and Geography
11.5. Analysis of Enrolled Patient Population
11.5.1. Analysis by Trial Status
11.5.2. Analysis by Phase of Development
11.5.3. Analysis by Geography
11.6. Analysis of Focus Therapeutic Areas
11.6.1. Analysis by Type of Sponsor
11.6.2. Analysis by Geography
11.6.2.1. North American Scenario
11.6.2.2. European Scenario
11.6.2.3. Asia Pacific Scenario
11.6.2.4. Rest of the World Scenario
11.6.3. Cardiovascular Disorders
11.6.3.1. Analysis by Trial Start Year
11.6.3.2. Analysis by Type of Sponsor
11.6.3.3. Analysis by Geography
11.6.4. Oncological Disorders
11.6.4.1. Analysis by Trial Start Year
11.6.4.2. Analysis by Type of Sponsor
11.6.4.3. Analysis by Geography
11.6.5. Central Nervous System (CNS) Disorders
11.6.5.1. Analysis by Trial Start Year
11.6.5.2. Analysis by Type of Sponsor
11.6.5.3. Analysis by Geography
11.6.6. Orthopedic Disorders
11.6.6.1. Analysis by Trial Start Year
11.6.6.2. Analysis by Type of Sponsor
11.6.6.3. Analysis by Geography
11.6.7. Respiratory Disorders
11.6.7.1. Analysis by Trial Start Year
11.6.7.2. Analysis by Type of Sponsor
11.6.7.3. Analysis by Geography
12. MERGERS AND ACQUISITIONS
12.1. Chapter Overview
12.2. Merger and Acquisition Models
12.3. Medical Device Contract Manufacturing: Mergers and Acquisitions
12.3.1. Analysis by Year of Mergers and Acquisitions
12.3.2. Analysis by Type of Acquisition
12.3.3. Most Active Acquirers: Analysis by Number of Acquisitions
12.3.4. Analysis by Key Value Drivers
12.3.4.1. Continent-wise distribution
12.3.4.2. Intercontinental and Intracontinental Deals
12.3.4.3. Country-wise distribution
12.3.5. Ownership Change Matrix
12.3.6. Acquisitions Made by Medical Device Companies
12.3.6.1. Acquisition of Entire Company
12.3.6.1.1. Analysis by Key Value Drivers
12.3.6.1.2. Analysis by Key Value Drivers and Year of Acquisition
12.3.6.1.3. Analysis by Type of Services Offered
12.3.6.1.4. Analysis by Type of Device
12.3.6.1.5. Analysis by Therapeutic Area
12.3.6.2. Acquisition of Company Assets
12.3.6.2.1. Analysis by Key Value Drivers
12.3.6.2.2. Analysis by Key Value Drivers and Year of Acquisition
12.3.7. Acquisition by Private Equity Firms
12.3.7.1. Analysis by Year of Acquisition
12.3.7.2. Analysis by Type of Acquisition
12.3.7.3. Analysis by Type of Device
12.3.7.4. Analysis by Therapeutic Area
12.4. Key Acquisitions: Deal Multiples
12.4.1. Analysis by Revenues
13. CASE STUDY: OFFSHORING MEDICAL DEVICE CONTRACT MANUFACTURING
13.1. Chapter Overview
13.2. Emerging Markets: Definitions and Key Regions
13.3. Role of Emerging Markets in Industrial Manufacturing
13.3.1. Contributions to the Automobile Industry
13.3.2. Contributions to the Aerospace and Defense Industries
13.4. Medical Devices Manufacturing in Emerging Markets
13.4.1. The US-Chinese Scenario
13.4.2. Partnership with Companies in Emerging Markets
13.5. Multinational Companies Focused on Manufacturing Medical Devices in Emerging Markets
13.6. Business Models for Medical Device Manufacturing in Emerging Markets
13.6.1. Case Studies
13.6.1.1. Study A: Overview
13.6.1.1.1. Value Proposition
13.6.1.1.2. Value Creation
13.6.1.2. Study B: Overview
13.6.1.2.1. Value Proposition
13.6.1.2.2. Value Creation
13.7. Key Challenges related to Innovation in the Medical Device Industry
13.7.1. Limitations of In-House Innovation
13.8. Advantages of Establishing Innovation Hubs in Emerging Markets
13.8.1. Challenges and Market Restraints
13.8.2. Strategies to Address Existing Challenges
13.9. Future Perspectives
14. MARKET FORECAST
14.1. Chapter Overview
14.2. Forecast Methodology and Key Assumptions
14.3. Overall Medical Device Contract Manufacturing Market, 2019-2030
14.3.1. Medical Device Contract Manufacturing Market: Distribution by Application Areas, 2019, 2025 and 2030
14.3.1.1. Medical Device Contract Manufacturing Market for Therapeutic Devices, 2019-2030
14.3.1.2. Medical Device Contract Manufacturing Market for Diagnostic Devices, 2019-2030
14.3.1.3. Medical Device Contract Manufacturing Market for Drug Delivery Devices, 2019-2030
14.3.1.4. Medical Device Contract Manufacturing Market for Other Devices, 2019-2030
14.3.2. Medical Device Contract Manufacturing Market: Distribution by Device Class, 2019 and 2030
14.3.2.1. Medical Device Contract Manufacturing Market: Class I Devices, 2019-2030
14.3.2.2. Medical Device Contract Manufacturing Market: Class II Devices, 2019-2030
14.3.2.3. Medical Device Contract Manufacturing Market: Class III Devices, 2019-2030
14.3.3. Medical Device Contract Manufacturing Market: Leading Players, 2019-2030
14.3.4. Medical Device Contract Manufacturing Market: Distribution by Therapeutic Areas, 2019 and 2030
14.3.4.1. Medical Device Contract Manufacturing Market for Cardiovascular Disorders, 2019-2030
14.3.4.2. Medical Device Contract Manufacturing Market for CNS Disorders, 2019-2030
14.3.4.3. Medical Device Contract Manufacturing Market for Metabolic Disorders, 2019-2030
14.3.4.4. Medical Device Contract Manufacturing Market for Oncological Disorders, 2019-2030
14.3.4.5. Medical Device Contract Manufacturing Market for Orthopedic Disorders, 2019-2030
14.3.4.6. Medical Device Contract Manufacturing Market for Ophthalmic Disorders, 2019-2030
14.3.4.7. Medical Device Contract Manufacturing Market for Pain Disorders, 2019-2030
14.3.4.8. Medical Device Contract Manufacturing Market for Respiratory Disorders, 2019-2030
14.3.4.9. Medical Device Contract Manufacturing Market for Other Therapeutic Areas, 2019-2030
14.4. Medical Device Contract Manufacturing Market: Distribution by Geography, 2019, 2025 and 2030
14.4.1. Medical Device Contract Manufacturing Market in North America, 2019-2030
14.4.1.1. Medical Device Contract Manufacturing Market in the US, 2019-2030
14.4.1.2. Medical Device Contract Manufacturing Market in Rest of North America, 2019-2030
14.4.1.3. Medical Device Contract Manufacturing Market in North America: Class I Devices, 2019-2030
14.4.1.4. Medical Device Contract Manufacturing Market in North America: Class II Devices, 2019-2030
14.4.1.5. Medical Device Contract Manufacturing Market in North America: Class III Devices, 2019-2030
14.4.1.6. Medical Device Contract Manufacturing Market in North America for Cardiovascular Disorders, 2019-2030
14.4.1.7. Medical Device Contract Manufacturing Market in North America for CNS Disorders, 2019-2030
14.4.1.8. Medical Device Contract Manufacturing Market in North America for Metabolic Disorders, 2019-2030
14.4.1.9. Medical Device Contract Manufacturing Market in North America for Oncological Disorders, 2019-2030
14.4.1.10. Medical Device Contract Manufacturing Market in North America for Orthopedic Disorders, 2019-2030
14.4.1.11. Medical Device Contract Manufacturing Market in North America for Ophthalmic Disorders, 2019-2030
14.4.1.12. Medical Device Contract Manufacturing Market in North America for Pain Disorders, 2019-2030
14.4.1.13. Medical Device Contract Manufacturing Market in North America for Respiratory Disorders, 2019-2030
14.4.1.14. Medical Device Contract Manufacturing Market for Other Therapeutic Areas in North America, 2019-2030
14.4.2. Medical Device Contract Manufacturing Market in Europe, 2019-2030
14.4.2.1. Medical Device Contract Manufacturing Market in Italy, 2019-2030
14.4.2.2. Medical Device Contract Manufacturing Market in Germany, 2019-2030
14.4.2.3. Medical Device Contract Manufacturing Market in France, 2019-2030
14.4.2.4. Medical Device Contract Manufacturing Market in Spain, 2019-2030
14.4.2.5. Medical Device Contract Manufacturing Market in the UK, 2019-2030
14.4.2.6. Medical Device Contract Manufacturing Market in Rest of Europe, 2019-2030
14.4.2.7. Medical Device Contract Manufacturing Market in Europe: Class I Devices, 2019-2030
14.4.2.8. Medical Device Contract Manufacturing Market in Europe: Class II Devices, 2019-2030
14.4.2.9. Medical Device Contract Manufacturing Market in Europe: Class III Devices, 2019-2030
14.4.2.10. Medical Device Contract Manufacturing Market in Europe for Cardiovascular Disorders, 2019-2030
14.4.2.11. Medical Device Contract Manufacturing Market in Europe for CNS Disorders, 2019-2030
14.4.2.12. Medical Device Contract Manufacturing Market in Europe for Metabolic Disorders, 2019-2030
14.4.2.13. Medical Device Contract Manufacturing Market in Europe for Oncological Disorders, 2019-2030
14.4.2.14. Medical Device Contract Manufacturing Market in Europe for Orthopedic Disorders, 2019-2030
14.4.2.15. Medical Device Contract Manufacturing Market in Europe for Ophthalmic Disorders, 2019-2030
14.4.2.16. Medical Device Contract Manufacturing Market in Europe for Pain Disorders, 2019-2030
14.4.2.17. Medical Device Contract Manufacturing Market in Europe for Respiratory Disorders, 2019-2030
14.4.2.18. Medical Device Contract Manufacturing Market in Europe for Other Therapeutic Areas, 2019-2030
14.4.3. Medical Device Contract Manufacturing Market in Asia Pacific, 2019-2030
14.4.3.1. Medical Device Contract Manufacturing Market in China, 2019-2030
14.4.3.2. Medical Device Contract Manufacturing Market in Japan, 2019-2030
14.4.3.3. Medical Device Contract Manufacturing Market in India, 2019-2030
14.4.3.4. Medical Device Contract Manufacturing Market in Rest of Asia Pacific, 2019-2030
14.4.3.5. Medical Device Contract Manufacturing Market in Asia Pacific: Class I Devices, 2019-2030
14.4.3.6. Medical Device Contract Manufacturing Market in Asia Pacific: Class II Devices, 2019-2030
14.4.3.7. Medical Device Contract Manufacturing Market in Asia Pacific: Class III Devices, 2019-2030
14.4.3.8. Medical Device Contract Manufacturing Market in Asia Pacific for Cardiovascular Disorders, 2019-2030
14.4.3.9. Medical Device Contract Manufacturing Market in Asia Pacific for CNS Disorders, 2019-2030
14.4.3.10. Medical Device Contract Manufacturing Market in Asia Pacific for Metabolic Disorders, 2019-2030
14.4.3.11. Medical Device Contract Manufacturing Market in Asia Pacific for Oncological Disorders, 2019-2030
14.4.3.12. Medical Device Contract Manufacturing Market in Asia Pacific for Orthopedic Disorders, 2019-2030
14.4.3.13. Medical Device Contract Manufacturing Market in Asia Pacific for Ophthalmic Disorders, 2019-2030
14.4.3.14. Medical Device Contract Manufacturing Market in Asia Pacific for Pain Disorders, 2019-2030
14.4.3.15. Medical Device Contract Manufacturing Market in Asia Pacific for Respiratory Disorders, 2019-2030
14.4.3.16. Medical Device Contract Manufacturing Market in Asia Pacific for Other Therapeutic Areas, 2019-2030
14.4.4. Medical Device Contract Manufacturing Market in Rest of the World, 2019-2030
14.4.4.1. Medical Device Contract Manufacturing Market in Rest of the World: Class I Devices, 2019-2030
14.4.4.2. Medical Device Contract Manufacturing Market in Rest of the World: Class II Devices, 2019-2030
14.4.4.3. Medical Device Contract Manufacturing Market in Rest of the World: Class III Devices, 2019-2030
14.4.4.4. Medical Device Contract Manufacturing Market in Rest of the World for Cardiovascular Disorders, 2019-2030
14.4.4.5. Medical Device Contract Manufacturing Market in Rest of the World for CNS Disorders, 2019-2030
14.4.4.6. Medical Device Contract Manufacturing Market in Rest of the World for Metabolic Disorders, 2019-2030
14.4.4.7. Medical Device Contract Manufacturing Market in Rest of the World for Oncological Disorders, 2019-2030
14.4.4.8. Medical Device Contract Manufacturing Market in Rest of the World for Orthopedic Disorders, 2019-2030
14.4.4.9. Medical Device Contract Manufacturing Market in Rest of the World for Ophthalmic Disorders, 2019-2030
14.4.4.10. Medical Device Contract Manufacturing Market in Rest of the World for Pain Disorders, 2019-2030
14.4.4.11. Medical Device Contract Manufacturing Market in Rest of the World for Respiratory Disorders, 2019-2030
14.4.4.12. Medical Device Contract Manufacturing Market in Rest of the World for Other Therapeutic Areas, 2019-2030
15. SWOT ANALYSIS
15.1. Chapter Overview
15.2. Strengths
15.3. Weaknesses
15.4. Opportunities
15.5. Threats
15.6. Concluding Remarks
16. CONCLUSION
16.1. Chapter Overview
16.2. Key Takeaways
17. SURVEY / INTERVIEW TRANSCRIPTS
18. APPENDIX 1: TABULATED DATA
19. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Figure 3.1. Historical Timeline of Medical Devices
Figure 3.2. Medical Device Manufacturing Process
Figure 3.3. Challenges Associated with Medical Device Manufacturing
Figure 3.4. Advantages offered by Automation
Figure 3.5. Services Offered by CMOs
Figure 3.6. Advantages of Outsourcing to CMOs
Figure 3.7. Risks Associated with Outsourcing to CMOs
Figure 3.8. Key Considerations while Selecting a CMO
Figure 4.1. US FDA: Review / Approval Process
Figure 4.2. Health Canada: Review / Approval Process
Figure 4.3. Summary of CE Marking Process
Figure 4.4. China Food and Drug Administration: Review / Approval Process
Figure 4.5. Pharmaceuticals and Medical Devices Agency: Review / Approval Process
Figure 4.6. Therapeutic Goods Administration: Review / Approval Process
Figure 4.7. Heat Map Analysis: Regional Regulatory Control Comparison
Figure 5.1. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Year of Establishment
Figure 5.2. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Size of Employee Base
Figure 5.3. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Headquarters (Region-wise)
Figure 5.4. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Headquarters (Country-wise)
Figure 5.5. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Year of Establishment, Location of Headquarters and Size of Employee Base
Figure 5.6. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Manufacturing Facility (Region-wise)
Figure 5.7. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Manufacturing Facility (Country-wise)
Figure 5.8. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Regulatory Certifications / Accreditations
Figure 5.9. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Type of Production Services Offered
Figure 5.10. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Type of Post-production Services Offered
Figure 5.11. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Type of Other Services Offered
Figure 5.12. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Device Class
Figure 5.13. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Type of Material(s) Handled
Figure 5.14. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Scale of Operation
Figure 5.15. Medical Device CMOs Offering Services for Therapeutic Devices: Leading Players
Figure 6.1. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Year of Establishment
Figure 6.2. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Size of Employee Base
Figure 6.3. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Headquarters (Region-wise)
Figure 6.4. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Headquarters (Country-wise)
Figure 6.5. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Year of Establishment, Location of Headquarters and Size of Employee Base
Figure 6.6. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Manufacturing Facility (Region-wise)
Figure 6.7. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Manufacturing Facility (Country-wise)
Figure 6.8. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Regulatory Certifications / Accreditations
Figure 6.9. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Type of Production Services Offered
Figure 6.10. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Type of Post-Production Services Offered
Figure 6.11. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Type of Other Services Offered
Figure 6.12. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Device Class
Figure 6.13. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Type of Material(s) Handled
Figure 6.14. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Scale of Operation
Figure 6.15. Medical Device CMOs Offering Services for Diagnostic Devices: Leading Players
Figure 7.1. Medical Device CMOs Offering Services for Catheters: Distribution by Year of Establishment
Figure 7.2. Medical Device CMOs Offering Services for Catheters: Distribution by Size of Employee Base
Figure 7.3. Medical Device CMOs Offering Services for Catheters: Distribution by Location of Headquarters (Region-wise)
Figure 7.4. Medical Device CMOs Offering Services for Catheters: Distribution by Location of Headquarters (Country-wise)
Figure 7.5. Medical Device CMOs Offering Services for Catheters: Distribution by Year of Establishment, Location of Headquarters and Size of Employee Base
Figure 7.6. Medical Device CMOs Offering Services for Catheters: Distribution by Location of Manufacturing Facility (Region-wise)
Figure 7.7. Medical Device CMOs Offering Services for Catheters: Distribution by Location of Manufacturing Facility (Country-wise)
Figure 7.8. Medical Device CMOs Offering Services for Catheters: Distribution by Regulatory Certifications / Accreditations
Figure 7.9. Medical Device CMOs Offering Services for Catheters: Distribution by Type of Production Services Offered
Figure 7.10. Medical Device CMOs Offering Services for Catheters: Distribution by Type of Post-Production Services Offered
Figure 7.11. Medical Device CMOs Offering Services for Catheters: Distribution by Type of Other Services Offered
Figure 7.12. Medical Device CMOs Offering Services for Catheters: Distribution by Device Class
Figure 7.13. Medical Device CMOs Offering Services for Catheters: Distribution by Type of Material(s) Handled
Figure 7.14. Medical Device CMOs Offering Services for Catheters: Distribution by Scale of Operation
Figure 7.15. Medical Device CMOs Offering Services for Catheters: Leading Players
Figure 7.16. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Year of Establishment
Figure 7.17. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Size of Employee Base
Figure 7.18. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Headquarters (Region-wise)
Figure 7.19. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Headquarters (Country-wise)
Figure 7.20. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Year of Establishment, Location of Headquarters and Size of Employee Base
Figure 7.21. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Manufacturing Facility (Region-wise)
Figure 7.22. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Manufacturing Facility (Country-wise)
Figure 7.23. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Regulatory Certifications / Accreditations
Figure 7.24. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Type of Production Services Offered
Figure 7.25. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Type of Post-Production Services Offered
Figure 7.26. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Type of Other Services Offered
Figure 7.27. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Device Class
Figure 7.28. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Type of Material(s) Handled
Figure 7.29. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Scale of Operation
Figure 7.30. Medical Device CMOs Offering Services for Drug Delivery Devices: Leading Players
Figure 7.31. Medical Device CMOs Offering Services for Other Devices: Distribution by Year of Establishment
Figure 7.32. Medical Device CMOs Offering Services for Other Devices: Distribution by Size of Employee Base
Figure 7.33. Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Headquarters (Region-wise)
Figure 7.34. Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Headquarters (Country-wise)
Figure 7.35. Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Manufacturing Facility (Region-wise)
Figure 7.36. Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Manufacturing Facility (Country-wise)
Figure 7.37. Medical Device CMOs Offering Services for Other Devices: Distribution by Regulatory Certifications / Accreditations
Figure 7.38. Medical Device CMOs Offering Services for Other Devices: Distribution by Type of Production Services Offered
Figure 7.39. Medical Device CMOs Offering Services for Other Devices: Distribution by Type of Post-Production Services Offered
Figure 7.40. Medical Device CMOs Offering Services for Other Devices: Distribution by Type of Other Services Offered
Figure 7.41. Medical Device CMOs Offering Services for Other Devices: Distribution by Device Class
Figure 7.42. Medical Device CMOs Offering Services for Other Devices: Distribution by Type of Material(s) Handled
Figure 7.43. Medical Device CMOs Offering Services for Other Devices: Distribution by Scale of Operation
Figure 8.1. Benchmark Analysis: Distribution by Region and Size of Employee Base
Figure 8.2. Benchmark Analysis: North America, Peer Group I
Figure 8.3. Benchmark Analysis: North America, Peer Group II
Figure 8.4. Benchmark Analysis: North America, Peer Group III
Figure 8.5. Benchmark Analysis: North America, Peer Group IV
Figure 8.6. Benchmark Analysis: North America, Peer Group V
Figure 8.7. Benchmark Analysis: North America, Peer Group VI
Figure 8.8. Benchmark Analysis: North America, Peer Group VII
Figure 8.9. Benchmark Analysis: Europe, Peer Group VIII
Figure 8.10. Benchmark Analysis: Europe, Peer Group IX
Figure 8.11. Benchmark Analysis: Europe, Peer Group X
Figure 8.12. Benchmark Analysis: Asia, Peer Group XI
Figure 8.13. Benchmark Analysis: Asia, Peer Group XII
Figure 8.14. Benchmark Analysis: Comparison Across Peer Groups
Figure 9.1. Medical Device Value Chain Operations
Figure 9.2. Business Units Impacted During Supply Chain Optimization
Figure 9.3. Post-optimization Events of Supply Chain Network
Figure 9.4. Comparative Analysis of Factors Impacting the Cost of Medical Device Supply Chain within Economies
Figure 10.1. Cirtec Medical: Production-related Service Portfolio
Figure 10.2. Cirtec Medical: Post-production Service Portfolio
Figure 10.3. DynaFlex Technologies: Production-related Service Portfolio
Figure 10.4. DynaFlex Technologies: Post-production Service Portfolio
Figure 10.5. I-Tek Medical Technologies: Production-related Service Portfolio
Figure 10.6. I-Tek Medical Technologies: Post-production Service Portfolio
Figure 10.7. Keystone Solutions Group: Production-related Service Portfolio
Figure 10.8. Keystone Solutions Group: Post-production Service Portfolio
Figure 10.9. Oscor: Production-related Service Portfolio
Figure 10.10. Oscor: Post-production Service Portfolio
Figure 10.11. SMC: Production-related Service Portfolio
Figure 10.12. SMC: Post-production Service Portfolio
Figure 10.13. Stellartech Research: Production-related Service Portfolio
Figure 10.14. Stellartech Research: Post-production Service Portfolio
Figure 10.15. Creganna Medical: Production-related Service Portfolio
Figure 10.16. Creganna Medical: Post-production Service Portfolio
Figure 10.17. Europlaz Technologies: Production-related Service Portfolio
Figure 10.18. Europlaz Technologies: Post-production Service Portfolio
Figure 10.19. Riverside Medical Packaging: Production-related Service Portfolio
Figure 10.20. Riverside Medical Packaging: Post-production Service Portfolio
Figure 10.21. Synecco: Production-related Service Portfolio
Figure 10.22. Synecco: Post-production Service Portfolio
Figure 10.23. Trelleborg Sealing Solutions: Production-related Service Portfolio
Figure 10.24. Trelleborg Sealing Solutions: Post-production Service Portfolio
Figure 10.25. Interplex: Production-related Service Portfolio
Figure 10.26. Interplex: Post-production Service Portfolio
Figure 10.27. Modern Medical: Production-related Service Portfolio
Figure 10.28. Modern Medical: Post-production Service Portfolio
Figure 10.29. Providence Enterprise: Production-related Service Portfolio
Figure 10.30. Providence Enterprise: Post-production Service Portfolio
Figure 10.31. Suzhou Jenitek: Production-related Service Portfolio
Figure 10.32. Suzhou Jenitek: Post-production Service Portfolio
Figure 11.1. Clinical Trial Analysis: Word Cloud of Trial Titles
Figure 11.2. Clinical Trial Analysis: Distribution of Trials by Start Year, 2013-Q1 2019
Figure 11.3. Clinical Trial Analysis: Distribution by Trial Status
Figure 11.4. Clinical Trial Analysis: Distribution by Phase of Development
Figure 11.5. Clinical Trial Analysis: Top 10 Target Indications
Figure 11.6. Clinical Trial Analysis: Distribution by Type of Sponsor
Figure 11.7. Clinical Trial Analysis: Distribution by Geography
Figure 11.8. Clinical Trial Analysis: Distribution by Trial Start Year and Geography (2013-2018)
Figure 11.9. Enrolled Patient Population: Distribution by Trial Status
Figure 11.10. Enrolled Patient Population: Distribution by Phase of Development
Figure 11.11. Enrolled Patient Population: Distribution by Geography
Figure 11.12. Clinical Trial Analysis: Distribution by Focus Therapeutic Areas
Figure 11.13. Heat Map Analysis: Emerging Therapeutic Areas
Figure 11.14. Clinical Trial Analysis: Distribution by Type of Sponsor and Top 10 Therapeutic Areas
Figure 11.15. Clinical Trial Analysis: Prominent Therapeutic Areas in North America
Figure 11.16. Clinical Trial Analysis: Prominent Therapeutic Areas in Europe
Figure 11.17. Clinical Trial Analysis: Prominent Therapeutic Areas in Asia Pacific
Figure 11.18. Clinical Trial Analysis: Prominent Therapeutic Areas in Rest of the World
Figure 11.19. Clinical Trials for Cardiovascular Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
Figure 11.20. Clinical Trials for Cardiovascular Disorders: Distribution by Sponsor Type
Figure 11.21. Clinical Trials for Cardiovascular Disorders: Distribution by Geography
Figure 11.22. Clinical Trials for Oncological Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
Figure 11.23. Clinical Trials for Oncological Disorders: Distribution by Sponsor Type
Figure 11.24. Clinical Trials for Oncological Disorders: Distribution by Geography
Figure 11.25. Clinical Trials for CNS Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
Figure 11.26. Clinical Trials for CNS Disorders: Distribution by Sponsor Type
Figure 11.27. Clinical Trials for CNS Disorders: Distribution by Geography
Figure 11.28. Clinical Trials for Orthopedic Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
Figure 11.29. Clinical Trials for Orthopedic Disorders: Distribution by Sponsor Type
Figure 11.30. Clinical Trials for Orthopedic Disorders: Distribution by Geography
Figure 11.31. Clinical Trials for Respiratory Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
Figure 11.32. Clinical Trials for Respiratory Disorders: Distribution by Sponsor Type
Figure 11.33. Clinical Trials for Respiratory Disorders: Distribution by Geography
Figure 12.1. Mergers and Acquisitions: Year-Wise Cumulative Trend (2014- 2019)
Figure 12.2. Mergers and Acquisitions: Distribution by Year and Type of Merger and Acquisition (2014 - 2018)
Figure 12.3. Mergers and Acquisitions: Distribution by Type of Acquisitions
Figure 12.4. Most Active Acquirers: Distribution by Number of Acquisitions
Figure 12.5. Mergers and Acquisitions: Continental Distribution
Figure 12.6. Mergers and Acquisitions: Intercontinental and Intracontinental Acquisitions
Figure 12.7. Mergers and Acquisitions: Country-wise Distribution
Figure 12.8. Mergers and Acquisitions: Ownership Change Matrix
Figure 12.9. Entire Company Acquisitions: Distribution by Key Value Drivers
Figure 12.10. Entire Company Acquisitions: Distribution by Key Value Drivers and Year of Acquisition (2014-2018)
Figure 12.11. Entire Company Acquisitions: Distribution by Services Offered
Figure 12.12. Mergers and Acquisitions: Distribution by Type of Device
Figure 12.13. Mergers and Acquisitions: Distribution by Therapeutic Area
Figure 12.14. Company Asset Acquisitions: Distribution by Key Value Drivers
Figure 12.15. Company Asset Acquisitions: Distribution by Key Value Drivers and Year of Acquisition
Figure 12.16. Private Equity Acquisitions: Year-Wise Cumulative Trend (2014-2019)
Figure 12.17. Private Equity Acquisitions: Distribution by Type of Acquisitions
Figure 12.18. Private Equity Acquisitions: Distribution by Type of Device
Figure 12.19. Private Equity Acquisitions: Distribution by Therapeutic Area
Figure 12.20. Comparison of Deal Multiples by Revenues of Acquired Companies
Figure 13.1. World Map Representation: Prominent Emerging Countries
Figure 14.1. Overall Medical Device CMOs Market, Base Scenario, 2019-2030 (USD Billion)
Figure 14.2. Medical Device CMOs Market: Distribution by Application Areas, 2019, 2025 and 2030 (USD Billion)
Figure 14.3. Medical Device CMOs Market for Therapeutic Devices, Base Scenario, 2019-2030 (USD Billion)
Figure 14.4. Medical Device CMOs Market for Diagnostic Devices, Base Scenario, 2019-2030 (USD Billion)
Figure 14.5. Medical Device CMOs Market for Drug Delivery Devices, Base Scenario, 2019-2030 (USD Billion)
Figure 14.6. Medical Device CMOs Market for Other Devices, Base Scenario, 2019-2030 (USD Billion)
Figure 14.7. Medical Device CMOs Market for Class I Devices, Base Scenario, 2019-2030 (USD Billion)
Figure 14.8. Medical Device CMOs Market for Class II Devices, Base Scenario, 2019-2030 (USD Billion)
Figure 14.9. Medical Device CMOs Market for Class III Devices, Base Scenario, 2019-2030 (USD Billion)
Figure 14.10. Medical Device CMOs Market: Distribution by Therapeutic Areas, 2019, 2025 and 2030 (USD Billion)
Figure 14.11. Medical Device CMOs Market for Cardiovascular Disorders, Base Scenario, 2019-2030 (USD Billion)
Figure 14.12. Medical Device CMOs Market for CNS Disorders, Base Scenario, 2019-2030 (USD Billion)
Figure 14.13. Medical Device CMOs Market for Metabolic Disorders, Base Scenario, 2019-2030 (USD Billion)
Figure 14.14. Medical Device CMOs Market for Oncological Disorders, Base Scenario, 2019-2030 (USD Billion)
Figure 14.15. Medical Device CMOs Market for Orthopedics, Base Scenario, 2019-2030 (USD Billion)
Figure 14.16. Medical Device CMOs Market for Ophthalmic Disorders, Base Scenario, 2019-2030 (USD Billion)
Figure 14.17. Medical Device CMOs Market for Pain Disorders, Base Scenario, 2019-2030 (USD Billion)
Figure 14.18. Medical Device CMOs Market for Respiratory Disorders, Base Scenario, 2019-2030 (USD Billion)
Figure 14.19. Medical Device CMOs Market for Other Therapeutic Areas, Base Scenario, 2019-2030 (USD Billion)
Figure 14.20. Medical Device CMOs Market: Distribution by Geography, 2019, 2025 and 2030 (USD Billion)
Figure 14.21. Medical Device CMOs Market in North America, Base Scenario, 2019-2030 (USD Billion)
Figure 14.22. Medical Device CMOs Market in the US, Base Scenario, 2019-2030 (USD Billion)
Figure 14.23. Medical Device CMOs Market in Rest of North America, Base Scenario, 2019-2030 (USD Billion)
Figure 14.24. Medical Device CMOs Market for Class I Devices in North America, Base Scenario, 2019-2030 (USD Billion)
Figure 14.25. Medical Device CMOs Market for Class II Devices in North America, Base Scenario, 2019-2030 (USD Billion)
Figure 14.26. Medical Device CMOs Market for Class III Devices in North America, Base Scenario, 2019-2030 (USD Billion)
Figure 14.27. Medical Device CMOs Market for Cardiovascular Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
Figure 14.28. Medical Device CMOs Market for CNS Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
Figure 14.29. Medical Device CMOs Market for Metabolic Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
Figure 14.30. Medical Device CMOs Market for Oncological Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
Figure 14.31. Medical Device CMOs Market for Orthopedics in North America, Base Scenario, 2019-2030 (USD Billion)
Figure 14.32. Medical Device CMOs Market for Ophthalmic Disorders, Base Scenario in North America, 2019-2030 (USD Billion)
Figure 14.33. Medical Device CMOs Market for Pain Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
Figure 14.34. Medical Device CMOs Market for Respiratory Disorders in North America, Base Scenario, 2019-2030 (USD Billion)
Figure 14.35. Medical Device CMOs Market for Other Therapeutic Areas in North America, Base Scenario, 2019-2030 (USD Billion)
Figure 14.36. Medical Device CMOs Market in Europe, Base Scenario, 2019-2030 (USD Billion)
Figure 14.37. Medical Device CMOs Market in Italy, Base Scenario, 2019-2030 (USD Billion)
Figure 14.38. Medical Device CMOs Market in Germany, Base Scenario, 2019-2030 (USD Billion)
Figure 14.39. Medical Device CMOs Market in France, Base Scenario, 2019-2030 (USD Billion)
Figure 14.40. Medical Device CMOs Market in Spain, Base Scenario, 2019-2030 (USD Billion)
Figure 14.41. Medical Device CMOs Market in the UK, Base Scenario, 2019-2030 (USD Billion)
Figure 14.42. Medical Device CMOs Market in Rest of Europe, Base Scenario, 2019-2030 (USD Billion)
Figure 14.43. Medical Device CMOs Market for Class I Devices in Europe, Base Scenario, 2019-2030 (USD Billion)
Figure 14.44. Medical Device CMOs Market for Class II Devices in Europe, Base Scenario, 2019-2030 (USD Billion)
Figure 14.45. Medical Device CMOs Market for Class III Devices in Europe, Base Scenario, 2019-2030 (USD Billion)
Figure 14.46. Medical Device CMOs Market for Cardiovascular Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
Figure 14.47. Medical Device CMOs Market for CNS Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
Figure 14.48. Medical Device CMOs Market for Metabolic Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
Figure 14.49. Medical Device CMOs Market of Oncological Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
Figure 14.50. Medical Device CMOs Market for Orthopedic Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
Figure 14.51. Medical Device CMOs Market for Ophthalmic Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
Figure 14.52. Medical Device CMOs Market for Pain Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
Figure 14.53. Medical Device CMOs Market for Respiratory Disorders in Europe, Base Scenario, 2019-2030 (USD Billion)
Figure 14.54. Medical Device CMOs Market for Other Therapeutic Areas in Europe, Base Scenario, 2019-2030 (USD Billion)
Figure 14.55. Medical Device CMOs Market in Asia Pacific, Base Scenario, 2019-2030 (USD Billion)
Figure 14.56. Medical Device CMOs Market in China, Base Scenario, 2019-2030 (USD Billion)
Figure 14.57. Medical Device CMOs Market in Japan, Base Scenario, 2019-2030 (USD Billion)
Figure 14.58. Medical Device CMOs Market in India, Base Scenario, 2019-2030 (USD Billion)
Figure 14.59. Medical Device CMOs Market in Rest of Asia Pacific, Base Scenario, 2019-2030 (USD Billion)
Figure 14.60. Medical Device CMOs Market for Class I Devices in Asia Pacific, Base Scenario, 2019-2030 (USD Billion)
Figure 14.61. Medical Device CMOs Market for Class II Devices in Asia Pacific, Base Scenario, 2019-2030 (USD Billion)
Figure 14.62. Medical Device CMOs Market for Class III Devices in Asia Pacific, Base Scenario, 2019-2030 (USD Billion)
Figure 14.63. Medical Device CMOs Market for Cardiovascular Disorders in Asia Pacific, Base Scenario, 2019-2030 (USD Billion)
Figure 14.64. Medical Device CMOs Market for CNS Disorders in Asia Pacific, Base Scenario, 2019-2030 (USD Billion)
Figure 14.65. Medical Device CMOs Market for Metabolic Disorders in Asia Pacific, Base Scenario, 2019-2030 (USD Billion)
Figure 14.66. Medical Device CMOs Market for Oncological Disorders in Asia Pacific, Base Scenario, 2019-2030 (USD Billion)
Figure 14.67. Medical Device CMOs Market for Orthopedic Disorders in Asia Pacific, Base Scenario, 2019-2030 (USD Billion)
Figure 14.68. Medical Device CMOs Market for Ophthalmic Disorders in Asia Pacific, Base Scenario, 2019-2030 (USD Billion)
Figure 14.69. Medical Device CMOs Market for Pain Disorders in Asia Pacific, Base Scenario, 2019-2030 (USD Billion)
Figure 14.70. Medical Device CMOs Market for Respiratory Disorders in Asia Pacific, Base Scenario, 2019-2030 (USD Billion)
Figure 14.71. Medical Device CMOs Market for Other Therapeutic Areas in Asia Pacific, Base Scenario, 2019-2030 (USD Billion)
Figure 14.72. Medical Device CMOs Market in Rest of the World, Base Scenario, 2019-2030 (USD Billion)
Figure 14.73. Medical Device CMOs Market for Class I Devices in Rest of the World, Base Scenario, 2019-2030 (USD Billion)
Figure 14.74. Medical Device CMOs Market for Class II Devices in Rest of the World, Base Scenario, 2019-2030 (USD Billion)
Figure 14.75. Medical Device CMOs Market for Class III Devices in Rest of the World, Base Scenario, 2019-2030 (USD Billion)
Figure 14.76. Medical Device CMOs Market for Cardiovascular Disorders in Rest of the World, Base Scenario, 2019-2030 (USD Billion)
Figure 14.77. Medical Device CMOs Market for CNS Disorders in Rest of the World, Base Scenario, 2019-2030 (USD Billion)
Figure 14.78. Medical Device CMOs Market for Metabolic Disorders in Rest of the World, Base Scenario, 2019-2030 (USD Billion)
Figure 14.79. Medical Device CMOs Market for Oncological Disorders in Rest of the World, Base Scenario, 2019-2030 (USD Billion)
Figure 14.80. Medical Device CMOs Market for Orthopedic Disorders in Rest of the World, Base Scenario, 2019-2030 (USD Billion)
Figure 14.81. Medical Device CMOs Market for Ophthalmic Disorders in Rest of the World, Base Scenario, 2019-2030 (USD Billion)
Figure 14.82. Medical Device CMOs Market for Pain Disorders in Rest of the World, Base Scenario, 2019-2030 (USD Billion)
Figure 14.83. Medical Device CMOs Market for Respiratory Disorders in Rest of the World, Base Scenario, 2019-2030 (USD Billion)
Figure 14.84. Medical Device CMOs Market for Other Therapeutic Areas in Rest of the World, Base Scenario, 2019-2030 (USD Billion)
Figure 15.1. Medical Device Contract Manufacturing SWOT Analysis: Overview
Figure 15.2. Comparison of SWOT Factors: Harvey Ball Analysis
Table 4.1. Device Classification: US
Table 4.2. Device Classification: Canada
Table 4.3. HTA Processes in Canada: Provincial Requirements
Table 4.4. Regulatory Bodies in EU5 Countries
Table 4.5. Device Classification: Europe
Table 4.6. List of CE Directives in Europe
Table 4.7. Conformity Assessment Modules in Europe
Table 4.8. Device Classification: China
Table 4.9. Device Classification: Japan
Table 4.10. Device Classification: Australia
Table 4.11. Medical Devices: Regulatory Landscape Summary
Table 5.1. List of Medical Device CMOs Offering Services for Therapeutic Devices
Table 5.2. List of Medical Device CMOs Offering Services for Therapeutic Devices: Information related to Manufacturing Facilities
Table 5.3. Medical Device CMOs Offering Services for Therapeutic Devices: Information on Regulatory Authorities / Standards
Table 5.4. Medical Device CMOs Offering Services for Therapeutic Devices: Information on Production Services
Table 5.5. Medical Device CMOs Offering Services for Therapeutic Devices: Information on Post-production Services
Table 5.6. Medical Device CMOs Offering Services for Therapeutic Devices: Information on Other Services
Table 5.7. Medical Device CMOs Offering Services for Therapeutic Devices: Information on Device Class
Table 5.8. Medical Device CMOs Offering Services for Therapeutic Devices: Information on Type of Material(s) Handled
Table 5.9. Medical Device CMOs Offering Services for Therapeutic Devices: Information on Scale of Operation
Table 6.1. List of Medical Device CMOs Offering Services for Diagnostic Devices
Table 6.2. List of Medical Device CMOs Offering Services for Diagnostic Devices: Information related to Manufacturing Facilities
Table 6.3. Medical Device CMOs Offering Services for Diagnostic Devices: Information on Regulatory Authorities / Standards
Table 6.4. Medical Device CMOs Offering Services for Diagnostic Devices: Information on Production Services
Table 6.5. Medical Device CMOs Offering Services for Diagnostic Devices: Information on Post-production Services
Table 6.6. Medical Device CMOs Offering Services for Diagnostic Devices: Information on Other Services
Table 6.7. Medical Device CMOs Offering Services for Diagnostic Devices: Information on Device Class
Table 6.8. Medical Device CMOs Offering Services for Diagnostic Devices: Information on Type of Material(s) Handled
Table 6.9. Medical Device CMOs Offering Services for Diagnostic Devices: Information on Scale of Operation
Table 7.1. List of Medical Device CMOs Offering Services for Catheters
Table 7.2. List of Medical Device CMOs Offering Services for Drug Delivery Devices: Information related to Manufacturing Facilities
Table 7.3. Medical Device CMOs Offering Services for Catheters: Information on Regulatory Authorities / Standards
Table 7.4. Medical Device CMOs Offering Services for Catheters: Information on Production Services
Table 7.5. Medical Device CMOs Offering Services for Catheters: Information on Post-production Services
Table 7.6. Medical Device CMOs Offering Services for Catheters: Information on Other Services
Table 7.7. Medical Device CMOs Offering Services for Catheters: Information on Device Class
Table 7.8. Medical Device CMOs Offering Services for Catheters: Information on Type of Material(s) Handled
Table 7.9. Medical Device CMOs Offering Services for Catheters: Information on Scale of Operation
Table 7.10. List of Medical Device CMOs Offering Services for Drug Delivery Devices
Table 7.11. List of Medical Device CMOs Offering Services for Drug Delivery Devices: Information related to Manufacturing Facilities
Table 7.12. Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Regulatory Authorities / Standards
Table 7.13. Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Production Services
Table 7.14. Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Post-production Services
Table 7.15. Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Other Services
Table 7.16. Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Device Class
Table 7.17. Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Type of Material(s) Handled
Table 7.18. Medical Device CMOs Offering Services for Drug Delivery Devices: Information on Scale of Operation
Table 7.19. List of Medical Device CMOs Offering Services for Other Medical Devices
Table 7.20. List of Medical Device CMOs Offering Services for Other Devices: Information related to Manufacturing Facilities
Table 7.21. Medical Device CMOs Offering Services for Other Devices: Information on Regulatory Authorities / Standards
Table 7.22. Medical Device CMOs Offering Services for Other Devices: Information on Production Services
Table 7.23. Medical Device CMOs Offering Services for Other Devices: Information on Post-Production Services
Table 7.24. Medical Device CMOs Offering Services for Other Devices: Information on Other Services
Table 7.25. Medical Device CMOs Offering Services for Other Devices: Information on Device Class
Table 7.26. Medical Device CMOs Offering Services for Other Devices: Information on Type of Material(s) Handled
Table 7.27. Medical Device CMOs Offering Services for Other Devices: Information on Scale of Operation
Table 8.1. Benchmark Analysis: Peer Groups
Table 10.1. Cirtec Medical: Company Overview
Table 10.2. Cirtec Medical: Future Outlook
Table 10.3. DynaFlex Technologies: Company Overview
Table 10.4. I-Tek Medical Technologies: Company Overview
Table 10.5. Keystone Solutions Group: Company Overview
Table 10.6. Keystone Solutions Group: Future Outlook
Table 10.7. Oscor: Company Overview
Table 10.8. Oscor: Future Outlook
Table 10.9. SMC: Company Overview
Table 10.9. SMC: Future Outlook
Table 10.11. Stellartech Research: Company Overview
Table 10.12. Creganna Medical: Company Overview
Table 10.13. Europlaz Technologies: Company Overview
Table 10.14. Riverside Medical Packaging: Company Overview
Table 10.15. Riverside Medical Packaging: Future Outlook
Table 10.16. Synecco: Company Overview
Table 10.17. Synecco: Future Outlook
Table 10.18. Trelleborg Sealing Solutions: Company Overview
Table 10.19. Trelleborg Sealing Solutions: Future Outlook
Table 10.20. Interplex: Company Overview
Table 10.21. Modern Medical: Company Overview
Table 10.22. Providence Enterprise: Company Overview
Table 10.23. Suzhou Jenitek: Company Overview
Table 12.1. Medical Device Contract Manufacturing: List of and Acquisitions, 2014 – 2019
Table 12.2. Entire Company Acquisitions: Key Value Drivers
Table 12.3. Mergers and Acquisitions: Information on Type of Device
Table 12.4. Company Asset Acquisitions: Key Value Drivers
Table 12.5. Medical Device Contract Manufacturing: List of Acquisitions by Private Equity Firms, 2014 – 2019
Table 12.6. Deal Multiples: Analysis by Revenues
Table 13.1. Medtech A: Company Overview
Table 13.2. Medtech A: Operational Values
Table 13.3. Medtech B: Company Overview
Table 13.4. Medtech A: Operational Values
Table 14.1. Medical Device CMOs Market: Distribution by Leading Players, 2018 (USD Billion)
Table 16.1. Medical Device Contract Manufacturing Market: Summary of Competitive Insights
Table 18.1. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Year of Establishment
Table 18.2. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Size of Employee Base
Table 18.3. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Headquarters (Region-wise)
Table 18.4. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Headquarters (Country-wise)
Table 18.5. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Year of Establishment, Location of Headquarters and Size of Employee Base
Table 18.6. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Manufacturing Facility (Region-wise)
Table 18.7. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Location of Manufacturing Facility (Country-wise)
Table 18.8. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Regulatory Certifications / Accreditations
Table 18.9. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Type of Production Services Offered
Table 18.10. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Type of Post-production Services Offered
Table 18.11. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Type of Other Services Offered
Table 18.12. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Device Class
Table 18.13. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Type of Material(s) Handled
Table 18.14. Medical Device CMOs Offering Services for Therapeutic Devices: Distribution by Scale of Operation
Table 18.15. Medical Device CMOs Offering Services for Therapeutic Devices: Leading Players
Table 18.16. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Year of Establishment
Table 18.17. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Size of Employee Base
Table 18.18. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Headquarters (Region-wise)
Table 18.19. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Headquarters (Country-wise)
Table 18.20. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Year of Establishment, Location of Headquarters and Size of Employee Base
Table 18.21. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Manufacturing Facility (Region-wise)
Table 18.22. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Location of Manufacturing Facility (Country-wise)
Table 18.23. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Regulatory Certifications / Accreditations
Table 18.24. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Type of Production Services Offered
Table 18.25. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Type of Post-production Services Offered
Table 18.26. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Type of Other Services Offered
Table 18.27. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Device Class
Table 18.28. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Type of Material(s) Handled
Table 18.29. Medical Device CMOs Offering Services for Diagnostic Devices: Distribution by Scale of Operation
Table 18.30. Medical Device CMOs Offering Services for Diagnostic Devices: Leading Players
Table 18.31. Medical Device CMOs Offering Services for Catheters: Distribution by Year of Establishment
Table 18.32. Medical Device CMOs Offering Services for Catheters: Distribution by Size of Employee Base
Table 18.33. Medical Device CMOs Offering Services for Catheters: Distribution by Location of Headquarters (Region-wise)
Table 18.34. Medical Device CMOs Offering Services for Catheters: Distribution by Location of Headquarters (Country-wise)
Table 18.35. Medical Device CMOs Offering Services for Catheters: Distribution by Year of Establishment, Location of Headquarters and Size of Employee Base
Table 18.36. Medical Device CMOs Offering Services for Catheters: Distribution by Location of Manufacturing Facility (Region-wise)
Table 18.37. Medical Device CMOs Offering Services for Catheters: Distribution by Location of Manufacturing Facility (Country-wise)
Table 18.38. Medical Device CMOs Offering Services for Catheters: Distribution by Regulatory Certifications / Accreditations
Table 18.39. Medical Device CMOs Offering Services for Catheters: Distribution by Type of Production Services Offered
Table 18.40. Medical Device CMOs Offering Services for Catheters: Distribution by Type of Post-production Services Offered
Table 18.41. Medical Device CMOs Offering Services for Catheters: Distribution by Type of Other Services Offered
Table 18.42. Medical Device CMOs Offering Services for Catheters: Distribution by Device Class
Table 18.43. Medical Device CMOs Offering Services for Catheters: Distribution by Type of Material(s) Handled
Table 18.44. Medical Device CMOs Offering Services for Catheters: Distribution by Scale of Operation
Table 18.45. Medical Device CMOs Offering Services for Catheters: Leading Players
Table 18.46. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Year of Establishment
Table 18.47. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Size of Employee Base
Table 18.48. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Headquarters (Region-wise)
Table 18.49. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Headquarters (Country-wise)
Table 18.50. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Year of Establishment, Location of Headquarters and Size of Employee Base
Table 18.51. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Manufacturing Facility (Region-wise)
Table 18.52. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Location of Manufacturing Facility (Country-wise)
Table 18.53. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Regulatory Certifications / Accreditations
Table 18.54. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Type of Production Services Offered
Table 18.55. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Type of Post-production Services Offered
Table 18.56. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Type of Other Services Offered
Table 18.57. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Device Class
Table 18.58. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Type of Material(s) Handled
Table 18.59. Medical Device CMOs Offering Services for Drug Delivery Devices: Distribution by Scale of Operation
Table 18.60. Medical Device CMOs Offering Services for Drug Delivery Devices: Leading Players
Table 18.61. Medical Device CMOs Offering Services for Other Devices: Distribution by Year of Establishment
Table 18.62. Medical Device CMOs Offering Services for Other Devices: Distribution by Size of Employee Base
Table 18.63. Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Headquarters (Region-wise)
Table 18.64. Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Headquarters (Country-wise)
Table 18.65. Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Manufacturing Facility (Region-wise)
Table 18.66. Medical Device CMOs Offering Services for Other Devices: Distribution by Location of Manufacturing Facility (Country-wise)
Table 18.67. Medical Device CMOs Offering Services for Other Devices: Distribution by Regulatory Certifications / Accreditations
Table 18.68. Medical Device CMOs Offering Services for Other Devices: Distribution by Type of Production Services Offered
Table 18.69. Medical Device CMOs Offering Services for Other Devices: Distribution by Type of Post-production Services Offered
Table 18.70. Medical Device CMOs Offering Services for Other Devices: Distribution by Type of Other Services Offered
Table 18.71. Medical Device CMOs Offering Services for Other Devices: Distribution by Device Class
Table 18.72. Medical Device CMOs Offering Services for Other Devices: Distribution by Type of Material(s) Handled
Table 18.73. Medical Device CMOs Offering Services for Other Devices: Distribution by Scale of Operation
Table 18.74. Clinical Trial Analysis: Distribution of Trials by Start Year, 2013-Q1 2019
Table 18.75. Clinical Trial Analysis: Distribution by Trial Status
Table 18.76. Clinical Trial Analysis: Distribution by Phase of Development
Table 18.77. Clinical Trial Analysis: Top 10 Target Indications
Table 18.78. Clinical Trial Analysis: Distribution by Type of Sponsor
Table 18.79. Clinical Trial Analysis: Distribution by Trial Start Year and Geography (2013-2018)
Table 18.80. Enrolled Patient Population: Distribution by Trial Status
Table 18.81. Enrolled Patient Population: Distribution by Phase of Development
Table 18.82. Clinical Trial Analysis: Distribution by Therapeutic Areas
Table 18.83. Clinical Trial Analysis: Distribution by Type of Sponsor and Top 10 Therapeutic Areas
Table 18.84. Clinical Trial Analysis: Prominent Therapeutic Areas in North America
Table 18.85. Clinical Trial Analysis: Prominent Therapeutic Areas in Europe
Table 18.86. Clinical Trial Analysis: Prominent Therapeutic Areas in Asia Pacific
Table 18.87. Clinical Trial Analysis: Prominent Therapeutic Areas in Rest of the World
Table 18.88. Clinical Trials for Cardiovascular Disorders: Distribution by Trial Start Year, 2013-Q1 2019
Table 18.89. Clinical Trials for Cardiovascular Disorders: Distribution by Type of Sponsor
Table 18.90. Clinical Trials for Cardiovascular Disorders: Distribution by Geography
Table 18.91. Clinical Trials for Oncological Disorders: Distribution by Trial Start Year, 2013-Q1 2019
Table 18.92. Clinical Trials for Oncological Disorders: Distribution by Sponsor Type
Table 18.93. Clinical Trials for Oncological Disorders: Distribution by Geography
Table 18.94. Clinical Trials for CNS Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
Table 18.95. Clinical Trials for CNS Disorders: Distribution by Sponsor Type
Table 18.96. Clinical Trials for CNS Disorders: Distribution by Geography
Table 18.97. Clinical Trials for Orthopedic Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
Table 18.98. Clinical Trials for Orthopedic Disorders: Distribution by Sponsor Type
Table 18.99. Clinical Trials for Orthopedic Disorders: Distribution by Geography
Table 18.100. Clinical Trials for Respiratory Disorders: Distribution of Trials by Start Year, 2013-Q1 2019
Table 18.101. Clinical Trials for Respiratory Disorders: Distribution by Type of Sponsor
Table 18.102. Clinical Trials for Respiratory Disorders: Distribution by Geography
Table 18.103. Mergers and Acquisitions: Year-Wise Cumulative Trend (2014- 2019)
Table 18.104. Mergers and Acquisitions: Distribution by Year and Type of Merger and Acquisition (2014 - 2018)
Table 18.105. Mergers and Acquisitions: Distribution by Type of Acquisitions
Table 18.106. Most Active Acquirers: Distribution by Number of Acquisitions
Table 18.107. Mergers and Acquisitions: Continental Distribution
Table 18.108. Mergers and Acquisitions: Country-wise Distribution
Table 18.109. Entire Company Acquisitions: Distribution by Key Value Drivers
Table 18.110. Mergers and Acquisitions: Distribution by Year and Type of Merger and Acquisition (2014 - 2018)
Table 18.111. Entire Company Acquisitions: Distribution by Services Offered
Table 18.112. Mergers and Acquisitions: Distribution by Type of Device
Table 18.113. Mergers and Acquisitions: Distribution by Therapeutic Area
Table 18.114. Company Asset Acquisitions: Distribution by Key Value Drivers
Table 18.115. Company Asset Acquisitions: Distribution by Key Value Drivers and Year of Acquisition
Table 18.116. Private Equity Acquisitions: Year-Wise Cumulative Trend (2014-2019)
Table 18.117. Private Equity Acquisitions: Distribution by Type of Acquisitions
Table 18.118. Private Equity Acquisitions: Distribution by Type of Device
Table 18.119. Private Equity Acquisitions: Distribution by Therapeutic Area
Table 18.120. Mergers and Acquisitions: Comparison of Deal Multiples by Revenues of Acquired Companies
Table 18.121. Overall Medical Device CMOs Market, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.122. Medical Device CMOs Market: Distribution by Application Areas, Base Scenario, 2019, 2025 and 2030 (USD Billion)
Table 18.123. Medical Device CMOs Market for Therapeutic Devices, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.124. Medical Device CMOs Market for Diagnostic Devices, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.125. Medical Device CMOs Market for Drug Delivery Devices, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.126. Medical Device CMOs Market for Other Devices, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.127. Medical Device CMOs Market for Class I Devices, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.128. Medical Device CMOs Market for Class II Devices, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.129. Medical Device CMOs Market for Class III Devices, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.130. Medical Device CMOs Market: Distribution by Therapeutic Areas, 2019, 2025 and 2030 (USD Billion)
Table 18.131. Medical Device CMOs Market for Cardiovascular Disorders, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.132. Medical Device CMOs Market for CNS Disorders, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.133. Medical Device CMOs Market for Metabolic Disorders, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.134. Medical Device CMOs Market for Oncological Disorders, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.135. Medical Device CMOs Market for Orthopedics, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.136. Medical Device CMOs Market for Ophthalmic Disorders, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.137. Medical Device CMOs Market for Pain Management, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.138. Medical Device CMOs Market for Respiratory Disorders, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.139. Medical Device CMOs Market for Other Therapeutic Areas, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.140. Medical Device CMOs Market in North America, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.141. Medical Device CMOs Market in the US, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.142. Medical Device CMOs Market in Rest of North America, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.143. Medical Device CMOs Market for Class I Devices in North America, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.144. Medical Device CMOs Market for Class II Devices in North America, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.145. Medical Device CMOs Market for Class III Devices in North America, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.146. Medical Device CMOs Market for Cardiovascular Disorders in North America, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Tale 18.147. Medical Device CMOs Market for CNS Disorders in North America, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.148. Medical Device CMOs Market for Metabolic Disorders in North America, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.149. Medical Device CMOs Market for Oncological Disorders in North America, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.150. Medical Device CMOs Market for Orthopedic Disorders in North America, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.151. Medical Device CMOs Market for Ophthalmic Disorders in North America, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.152. Medical Device CMOs Market for Pain Management in North America, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.153. Medical Device CMOs Market for Respiratory Disorders in North America, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.154. Medical Device CMOs Market for Other Therapeutic Areas in North America, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.155. Medical Device CMOs Market in Europe, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.156. Medical Device CMOs Market in Italy, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.157. Medical Device CMOs Market in Germany, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.158. Medical Device CMOs Market in France, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.159. Medical Device CMOs Market in Spain, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.160. Medical Device CMOs Market in UK, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.161. Medical Device CMOs Market in Rest of Europe, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.162. Medical Device CMOs Market for Class I Devices in Europe, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.163. Medical Device CMOs Market for Class II Devices in Europe, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.164. Medical Device CMOs Market for Class III Devices in Europe, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.165. Medical Device CMOs Market for Cardiovascular Disorders in Europe, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.166. Medical Device CMOs Market for CNS Disorders in Europe, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.167. Medical Device CMOs Market for Metabolic Disorders in Europe, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.168. Medical Device CMOs Market for Oncological Disorders in Europe, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.169. Medical Device CMOs Market for Orthopedic Disorders in Europe, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.170. Medical Device CMOs Market for Ophthalmic Disorders in Europe, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.171. Medical Device CMOs Market for Pain Management in Europe, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.172. Medical Device CMOs Market for Respiratory Disorders in Europe, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.173. Medical Device CMOs Market for Other Therapeutic Areas in Europe, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.174. Medical Device CMOs Market in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.175. Medical Device CMOs Market in China, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.176. Medical Device CMOs Market in Japan, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.177. Medical Device CMOs Market in India, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.178. Medical Device CMOs Market in Rest of Asia Pacific, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.179. Medical Device CMOs Market for Class I Devices in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.180. Medical Device CMOs Market for Class II Devices in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.181. Medical Device CMOs Market for Class III Devices in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.182. Medical Device CMOs Market for Cardiovascular Disorders in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.183. Medical Device CMOs Market for CNS Disorders in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.184. Medical Device CMOs Market for Metabolic Disorders in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.185. Medical Device CMOs Market for Oncological Disorders in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.186. Medical Device CMOs Market for Orthopedic Disorders in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.187. Medical Device CMOs Market for Ophthalmic Disorders in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.188. Medical Device CMOs Market for Pain Management in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.189. Medical Device CMOs Market for Respiratory Disorders in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.190. Medical Device CMOs Market for Other Therapeutic Areas in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.191. Medical Device CMOs Market in Rest of the World, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.192. Medical Device CMOs Market for Class I Devices in Rest of the World, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.193. Medical Device CMOs Market for Class II Devices in Rest of the World, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.194. Medical Device CMOs Market for Class III Devices in Rest of the World, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.195. Medical Device CMOs Market for Cardiovascular Disorders in Rest of the World, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.196. Medical Device CMOs Market for CNS Disorders in Rest of the World, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.197. Medical Device CMOs Market for Metabolic Disorders in Rest of the World, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.198. Medical Device CMOs Market for Oncological Disorders in Rest of the World, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.199. Medical Device CMOs Market for Orthopedic Disorders in Rest of the World, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.200. Medical Device CMOs Market for Ophthalmic Disorders in Rest of the World, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.201. Medical Device CMOs Market for Pain Management in Rest of the World, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.202. Medical Device CMOs Market for Respiratory Disorders in Rest of the World, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
Table 18.203. Medical Device CMOs Market for Other Therapeutic Areas in Rest of the World, Conservative, Base and Optimistic Scenarios, 2019-2030 (USD Billion)
The following companies and organizations have been mentioned in the report.
PRICING DETAILS
Discounts available for multiple report purchases
sales@rootsanalysis.com
SUBSCRIBE TO INDUSTRY UPDATES